A 19-year-old in Kelowna, B.C., has been cured of chronic granulomatous disease (CGD), a rare condition that left him vulnerable to life-threatening infections. Doctors at B.C. Children’s Hospital used a novel gene-editing technique to correct a defect in his DNA.
Dr. Stuart Turvey, a pediatric immunologist involved in the treatment, explained that CGD creates a significant vulnerability in the immune system, likened to a "hole in the suit of armor." Patients often require lifelong medication and face constant risk of severe infections.
Previously, the primary treatment was a bone marrow transplant, but Sperle did not have a suitable donor. He was enrolled in a clinical trial conducted by U.S.-based Prime Medicine, with a Canadian site at Montreal's Sainte-Justine University Hospital.
The revolutionary treatment involved correcting a "spelling mistake" in Sperle's DNA, essentially using his own cells to rebuild a functional immune system. This approach, building on decades of scientific research including CRISPR technology, represents a potential cure for such conditions.
Dr. Turvey expressed his delight, stating that the success means he can now view Sperle not just as a patient, but as a friend, free from the constant medical concerns associated with his former diagnosis.